New program aims to break down barriers to cancer trial participation

NCT ID NCT06484595

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This pilot study tested a program called GUIDE, which uses a trained navigator to help cancer patients overcome social and financial barriers to joining clinical trials. The study included 100 adults with cancer who were eligible for a trial and had at least one health-related social need. The goal was to see if the program is acceptable and feasible, with the hope of increasing diversity in cancer research.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Patient navigation program (GUIDE)
What this could lead to
If successful, this program could help more people from diverse backgrounds participate in cancer clinical trials, making future treatments more inclusive.
What could go wrong
This is a small pilot study focused on feasibility, not on proving that the program improves health outcomes. It may not work in larger or different settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEMATOPOIETIC AND LYMPHATIC SYSTEM NEOPLASM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Fred Hutch/University of Washington Cancer Consortium

    Seattle, Washington, 98109, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.